Written by Ufuk Avcu on 16 January 2017. Posted in Press Releases and Ad-hoc Announcements. PR: WILEX Signs Antibody License Agreement with Telix Pharmaceuticals Limited PDF File: images/files/press-releases-and-ad-hoc-announcements/2022/63741c5eb879c_20170116_PR_Wilex_Telix_Redectane_eng_final.pdf 2017 Created on 16 November 2022. Last updated on 16 November 2022. Hits: 1676 Prev Next